Table 2.
Correlation between FOXO3a, TGF-β, HO-1 and clinical indicators of AS patients.
| Indicators | FOXO3a | TGF-β | HO-1 | |||
|---|---|---|---|---|---|---|
| rs | P value | rs | P value | rs | P value | |
| ESR | 0.115 | 0.425 | -0.085 | 0.557 | 0.293 | 0.039 |
| CRP | -0.057 | 0.696 | -0.248 | 0.083 | 0.283 | 0.046 |
| BASDAI | 0.123 | 0.396 | -0.290 | 0.041 | 0.244 | 0.088 |
| BASFI | -0.704 | 0.016 | 0.068 | 0.641 | 0.151 | 0.297 |
| ASDAS | -0.032 | 0.827 | -0.068 | 0.641 | 0.366 | 0.009 |
| Disease duration | -0.193 | 0.570 | -0.198 | 0.167 | -0.111 | 0.441 |
AS, ankylosing spondylitis; ASDAS, Ankylosing Spondylitis Disease Activity Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.
rs, Spearman's rank correlation coefficient.
Statistical methods: Spearman rank correlation.
P values with bold were considered statistically significant differences.